WE‐AB‐207B‐02: A Bayesian Network Approach for Joint Prediction of Tumor Control and Radiation Pneumonitis (RP) in Non‐Small‐Cell Lung Cancer (NSCLC)

Abstract

Purpose:NSCLC radiotherapy treatment is a trade‐off between controlling the tumor while limiting radiation‐induced toxicities. Here we identify hierarchical biophysical relationships that could simultaneously influence both local control (LC) and RP by using an integrated Bayesian Networks (BN) approach.Methods:We studied 79 NSCLC patients treated on prospective protocol with 56 cases of LC and 21 events of RP. Beyond dosimetric information, each patient had 193 features including 12 clinical factors, 60 circulating blood cytokines before and during radiotherapy, 62 microRNAs, and 59 single‐nucleotide polymorphisms (SNPs). The most relevant biophysical predictors for both LC and RP were identified using a Markov blanket local discovery algorithm and the corresponding BN was constructed using a score‐learning algorithm. The area under the free‐response receiver operating characteristics (AU‐FROC) was used for performance evaluation. Cross‐validation was employed to guard against overfitting pitfalls.Results:A BN revealing the biophysical interrelationships jointly in terms of LC and RP was developed and evaluated. The integrated BN included two SNPs, one microRNA, one clinical factor, three pre‐treatment cytokines, relative changes of two cytokines between pre and during‐treatment, and gEUDs of the GTV (a=‐20) and lung (a=1). On cross‐validation, the AUC prediction of independent LC was 0.85 (95% CI: 0.75–0.95) and RP was 0.83 (0.73–0.92). The AU‐FROC of the integrated BN to predict both LC/RP was 0.81 (0.71–0.90) based on 2000 stratified bootstrap, indicating minimal loss in joint prediction power.Conclusions:We developed a new approach for multiple outcome utility application in radiotherapy based on integrated BN techniques. The BN developed from large‐scale retrospective data is able to simultaneously predict LC and RP in NSCLC treatments based on individual patient characteristics. The joint prediction is only slightly compromised compared to independent predictions. Our approach shows promise for use in clinical decision support system for personalized radiotherapy subject to multiple endpoints.These studies were supported by a grant from the NCI/NIH P01‐CA59827.